Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
β-Boswellic acid
Cat. No.:
0225LY-1463
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
β-Boswellic acid, along with its derivatives, serves as a major constituent of Boswellin with documented anti-hyperlipidemic and anti-tumor effects.
Synonym:
Beta-boswellic acid; 631-69-6; Beta-Boswellic acid; Boswellic acid; b-Boswellic acid; (3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid; (4R)-3alpha-Hydroxyurs-12-en-24-oic acid; Urs-12-en-24-oic acid, 3.alpha.-hydroxy-; ss-Boswellic acid; .3alpha-Hydroxyurs-12-en-24-oic acid; (3alpha,4beta)-3-hydroxy-Urs-12-en-23-oate
CAS No.:
631-69-6
Compound CID:
168928
Formula:
C30H48O3
Formula Weight:
456.7
Specification
Relative Density:
1.09 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
β-Boswellic acid can be used in inflammatory research to study the selective inhibition of 5-lipoxygenase and its role in managing chronic inflammation.
Library Information
Target:
Lipoxygenase
Receptor:
5-Lipoxygenase
Pathways:
Metabolism; DNA damage/DNA repair; Cell cycle/Checkpoint
Plate Number:
AOCL-19
Plate Location:
g6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
150 mg/mL; 328.44 mM
